Browser-based tools help side hustlers and independent workers create invoices, track income, document payments and ...

Many Venezuelans see the deal giving the United States control of roughly one-fifth of their country's oil reserves as a ...

Suppliers must generate valid eTIMS invoices for all supplies before submitting them for payment processing through Ifmis.

Hyderabad:A city-based plywood and hardware firm has approached the Telangana Cyber Security Bureau (TGCSB) after unidentified persons allegedly gained unauthorised access to its GST account, changed ...

Tern has also released further capabilities to reduce manual work surrounding advisor payouts, service fees and membership dues. Photo Credit: smx12/Shutterstock Tern has expanded its back-office ...

Aug 4 (Reuters) - Jefferies (JEF.N), opens new tab has been told that some of the invoices ‌underpinning its financing to an iron ore trader called Sapphire Minmetals Corp are not genuine, Bloomberg ...

Tax season is nigh upon us, and this year there is a meaningfully different option for the millions of Kenyan traders who have long found eTIMS too technical, too slow, or simply too much to deal with ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...